BiomX Inc. - Common Stock, $0.0001 par value (PHGE)
CUSIP: 09090D301
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 1,527,040
- Total 13F shares
- 13,299,821
- Share change
- +3,339,175
- Total reported value
- $7,390,820
- Price per share
- $0.56
- Number of holders
- 18
- Value change
- +$1,849,949
- Number of buys
- 10
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 09090D301?
CUSIP 09090D301 identifies PHGE - BiomX Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09090D301:
Top shareholders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
13,777,980
mixed-class rows
|
$5,250,517 | — | 15 May 2024 | |
| Cystic Fibrosis Foundation |
3/4/5
13D/G
|
10%+ Owner |
10%
from 13D/G
|
11,131,426
mixed-class rows
|
$1,663,688 | — | 26 Feb 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
10%
|
2,494,197
|
$1,496,518 | +$420,034 | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
117%
|
1,787,767
|
$1,305,249 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
117%
|
1,787,610
|
$1,305,134 | — | 31 Dec 2024 | |
| Chidozie Ugwumba |
3/4/5
|
Exit Form 4 - former 10% owner |
—
class O/S missing
|
2,997,025
|
$1,018,989 | — | 17 Oct 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
58%
|
892,976
|
$651,962 | — | 31 Dec 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
57%
|
865,400
|
$631,829 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
57%
|
865,400
|
$631,829 | — | 31 Dec 2024 | |
| Allostery Investments LP |
13F
|
Company |
42%
|
643,833
|
$470,062 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
28%
|
429,990
|
$313,936 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
26%
|
401,136
|
$292,869 | — | 31 Dec 2024 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
17%
|
258,492
|
$188,725 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
16%
|
237,376
|
$173,308 | — | 31 Dec 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.98%
|
96,866
|
$70,722 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
32,144
|
$23,468 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1.6%
|
25,000
|
$18,253 | — | 31 Dec 2024 | |
| Assaf Oron |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
263,304
mixed-class rows
|
$9,836 | — | 16 Sep 2024 | |
| Paul J. Sekhri |
3/4/5
|
Director |
—
mixed-class rows
|
21,875
mixed-class rows
|
$4,250 | — | 28 Jul 2021 | |
| CLEAR STREET LLC |
13F
|
Company |
0.16%
|
2,463
|
$1,798 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.02%
|
300
|
$219 | — | 31 Dec 2024 | |
| Carolina Wealth Advisors, LLC |
13F
|
Company |
0.01%
|
159
|
$116 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2024 | |
| Dambach Michael E. |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 21 Aug 2023 | |
| Lynne Marie Sullivan |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 01 Mar 2023 | |
| Marks Jason M. |
3/4/5
|
Director |
—
class O/S missing
|
41,000
|
— | — | 21 Aug 2023 | |
| Gbolahan Amusa |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 29 Mar 2022 | |
| Jonas Grossman |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 29 Mar 2022 |
Institutional Holders of BiomX Inc. - Common Stock, $0.0001 par value (PHGE) as of Q1 2025
As of 31 Mar 2025,
BiomX Inc. - Common Stock, $0.0001 par value (PHGE) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,299,821 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Nantahala Capital Management, LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., AIGH Capital Management LLC, Allostery Investments LP, Ikarian Capital, LLC, JPMORGAN CHASE & CO, DAFNA Capital Management LLC, and ADAR1 Capital Management, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
16
Q1 2025 holders
18
Holder diff
2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.